10/24/13 - 11:00 AM EDT
Iclusig may find use in other cancers and '113 is better than the market believes.
04/18/13 - 10:00 AM EDT
Through four reverse stock splits, Cell Therapeutics has lost 99% of its value.
01/24/13 - 08:00 AM EST
Instead of selling stock whenever the wind blows, biotech execs should be buying.
10/25/12 - 07:00 AM EDT
The strange but true tale of a beleaguered, bankrupt biotech firm with 100 quadrillion shares outstanding.
09/25/12 - 08:07 AM EDT
How best to invest in the next important clinical trial catalyst facing Celgene.